🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
STUDY JUSTIFICATION 1. Scientific evidence of the usefulness of corticoste...
Status
Completed
Location
Hospital Carlos Haya
Start Date
2010-12
Trial ID
NCT01261546
Treatments Being Tested
Patients who have this kind of cancer are often treated with several drugs....
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2010-11
Trial ID
NCT01248962
Treatments Being Tested
The purpose of this study is to see if the combination of bendamustine, len...
Status
Completed
Location
Karmanos Cancer Institute
Start Date
2008-02
Trial ID
NCT01042704
Many control mechanisms exist which successfully match the supply of blood ...
Status
Recruiting
Location
George E Wahlen VA Medical Center
Start Date
2008-09
Trial ID
NCT02966665
The purpose of this study is to explore the combination of Elotuzumab in co...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2016-01
Trial ID
NCT02655458
Treatments Being Tested
This study will examine the safety and effectiveness of ranitidine (Zantac)...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-09
Trial ID
NCT00527878
Treatments Being Tested
This open label Phase 1 study involves treating subjects with advanced canc...
Status
Completed
Location
Multiple Locations
Start Date
2011-08-24
Trial ID
NCT01411410
Treatments Being Tested
This is an investigator-initiated (IIS), phase 2, prospective, open-label, ...
Status
Unknown
Location
General Hospital of Athens "Evangelismos"
Start Date
2022-05
Trial ID
NCT05298683
The purpose of this study is to compare the efficacy of rabeprazole extende...
Status
Completed
Location
Ltd.
Start Date
2008-08-31
Trial ID
NCT00838526
Treatments Being Tested
The purpose of this study is to determine a recommended Phase 2 dose and do...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2007-11
Trial ID
NCT01287520
Treatments Being Tested